MET EBITDA Growth
MetLife · EBITDA Growth
MET EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-11.73%period ending
MET TTM EBITDA YoY % (455.92% → -11.73%)
Year-over-year change
High-resolution chart · PNG
MET ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -11.7299% | |
| -15.5128% | |
| -14.0712% | |
| -3.9653% | |
| 41.3439% | |
| 73.8761% | |
| 107.6395% | |
| 56.8228% | |
| -1.0358% | |
| -25.2288% | |
| -54.2053% | |
| -39.4328% | |
| -32.8277% | |
| -49.8924% | |
| -22.5846% | |
| -17.0923% | |
| 5.9882% | |
| 328.5084% | |
| 15.3827% | |
| 3.629% | |
| -28.594% | |
| -78.5684% | |
| 1.1613% | |
| -25.85% | |
| 10.0742% | |
| 55.8875% | |
| 4.3209% | |
| 70.7131% | |
| 58.1882% | |
| 39.6632% | |
| 56.137% | |
| 3,867.1053% | |
| 563.382% | |
| 2,050.7299% | |
| 196.4486% | |
| -97.5927% | |
| -88.8011% | |
| -103.2028% | |
| -81.505% | |
| -34.3386% | |
| -29.4095% | |
| -23.8811% | |
| -13.3932% | |
| 4.0918% | |
| 42.7512% | |
| 90.3625% | |
| 87.8515% | |
| 155.617% | |
| 339.8551% | |
| 31.9624% | |
| 85.4659% | |
| -15.224% | |
| -84.2196% | |
| -48.851% | |
| -72.6095% | |
| -52.2834% | |
| 150.8726% | |
| 75.01% | |
| 115.65% | |
| 66.8036% | |
| 13.4527% | |
| 476.9231% | |
| 229.7362% | |
| 294.7636% | |
| 8,479.5455% | |
| -137.5106% | |
| -152.9636% | |
| -135.3017% | |
| -100.5847% | |
| -56.3095% | |
| -16.0824% | |
| -0.8149% | |
| -3.8584% | |
| 15.9667% | |
| 63.5483% | |
| 61.3725% | |
| 75.4146% | |
| 39.4285% | |
| 2.685% | |
| 2.3769% | |
| -4.8817% | |
| 17.5476% | |
| 26.5861% | |
| 19.6577% | |
| 31.2168% | |
| 32.9897% | |
| 51.8929% | |
| 89.5515% | |
| 94.2935% | |
| 107.5875% | |
| 60.9231% | |
| 110.2307% | |
| 185.2713% | |
| 136.5031% | |
| 301.2346% | |
| -20.9984% | |
| -77.8122% | |
| -74.9808% | |
| -85.7143% | |
| -58.6501% |